Multi-channel prismatic localized surface plasmon resonance biosensor for real-time competitive assay multiple COVID-19 characteristic miRNAs.

Publication date: Aug 01, 2024

A multi-channel prismatic localized surface plasmon resonance (LSPR) biosensor was developed for quantitative and real-time detection of multiple COVID-19 characteristic miRNAs. The well-dispersed and dense gold nanoparticles (AuNPs) arrays for LSPR biosensing were fabricated through a nano-thickness diblock copolymer template (BCPT). Both theoretical and experimental analyses were conducted to investigate the effects of particle size, interparticle spacing, and surface coverage on LSPR sensing spectrum and intensity sensitivity of varied AuNPs sizes. A competitive assay strategy was proposed and used for non-amplification miRNA detection with a low limit detection of 3. 41 nM, while a four-channel prismatic LSPR system enables parallel detection of multiple miRNAs. Furthermore, this sensing strategy can effectively and specifically identify target miRNA, distinguish mismatched miRNA and interfering miRNA, and exhibit low non-specific adsorption. This BCPT-based LSPR biosensor demonstrates the practicality and potential of a multi-channel, adaptable, and integrated prismatic sensor in medical testing and diagnostic applications.

Concepts Keywords
41nm Biosensing Techniques
Adaptable Competitive detection
Covid COVID-19
Nanoparticles Gold
Target Gold
Gold nanoparticles
Humans
Limit of Detection
LSPR biosensing
Metal Nanoparticles
MicroRNAs
MicroRNAs
miRNA
Prismatic configuration
SARS-CoV-2
Surface Plasmon Resonance

Semantics

Type Source Name
disease VO time
disease IDO assay
disease MESH COVID-19
drug DRUGBANK Gold

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *